483
Bio-Thera Solutions, Ltd.FDA 483 - Bio-Thera Solutions, Ltd. - January 17, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Cosmetic Specialty Labs, Inc., a cosmetic manufacturer producing Over-the-Counter (OTC) drug products, was conducted from January 29 to February 8, 2024. The inspection revealed several significant deficiencies, many of which were repeat observations from a 2017 inspection, indicating a systemic lack of adherence to regulatory requirements.
Open in Dashboard
ID · 9293d03a-2296-45c6-a9d9-857d59110ceb